Page 29 - Service Testing News Today

By Chris Wack Portage Biotech shares were up 20% to $2.81 after the company entered into a clinical trial collaboration agreement with Merck to evaluate...

By Cecilia Butini Valneva has received positive safety data in a Phase 3 trial studying a vaccine against the mosquito-borne chikungunya virus. Data showed...

By Colin Kellaher Novocure on Monday said a phase 3 study of its Tumor Treating Fields, or TTFields, therapy in combination with paclitaxel missed its...

By Adria Calatayud Shares in Roche Holding rose Wednesday after the company released interim results from a late-stage clinical trial of a combination of two...

By Michael Susin GSK said that a trial showed 100% efficacy of its vaccine in the prevention of shingles in adults aged 50 and over in China. The British...

By Colin Kellaher Fulcrum Therapeutics shares surged in premarket trading Tuesday after the U.S. Food and Drug Administration lifted a full clinical hold on...

By Robb M. Stewart Vincerx Pharma's shares jumped ahead of the opening bell after the biopharmaceutical company received regulatory approval to begin an...

By Adria Calatayud Exelixis and Ipsen said a phase 3 clinical trial evaluating a combination of drugs cabozantinib and atezolizumab in metastatic...

By Colin Kellaher A late-stage study of Merck % Co.'s cancer drug Welireg has met a key goal in certain patients with the most common type of kidney cancer....

By Ben Glickman Shares of Design Therapeutics hit their third all-time low in four days after the company said patients in a trial of its drug developed...